Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study

Objectives: To evaluate transperineal intraprostatic injection of botulinum neurotoxin A (BoNT-A) in patients with lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH) who failed to respond to 6-month medical treatment compared with transurethral resection of the prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Dakhakhny, Amr S., Gharib, Tarek, Issam, Ahmed, El-Karamany, Tarek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Benign Prostatic Hyperplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830273/
https://www.ncbi.nlm.nih.gov/pubmed/31723444
http://dx.doi.org/10.1080/2090598X.2019.1662214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830273/
https://www.ncbi.nlm.nih.gov/pubmed/31723444
http://dx.doi.org/10.1080/2090598X.2019.1662214

Ejemplares similares